UK-based CDMO Pharmaterials Ltd has announced the promotions of Chris Landeg to VP, Operations and Martin Wing-King to Director, Business Development and Project Management. The company also said that it has hired Yogesh Davé as Senior Director of QA.
Landeg joined Pharmaterials in 2007 as Director of Business Development; Wing-King joined the company in 2008 as Business Development Manager and has most recently served as Associate Director, Business Development. Davé has worked in pharmaceutical quality assurance for over 28 years.
In 2014, Pharmaterials announced that it planned to quadruple its cGMP manufacturing capacity in Reading, UK; the company says that it is finalizing the expansion and expects the new manufacturing suites to begin operations in 2016.
